Aclaris Drug Patent Portfolio
Aclaris owns 1 orange book drug protected by 6 US patents Given below is the list of Aclaris's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9675639 | Peroxide formulations and methods and applicators for using the same | 04 Jul, 2035 | Active |
| US10098910 | Peroxide formulations and methods and applicators for using the same | 21 Apr, 2035 | Active |
| US10493103 | Peroxide formulations and methods and applicators for using the same | 21 Apr, 2035 | Active |
| US10729720 | Peroxide formulations and methods and applicators for using the same | 21 Apr, 2035 | Active |
| US9980983 | Peroxide formulations and methods and applicators for using the same | 21 Apr, 2035 | Active |
| US7381427 | Seborrheic keratosis treatment | 08 Jun, 2022 | Expired |
Latest Legal Activities on Aclaris's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Aclaris.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 08 Jan, 2024 | US10493103 |
|
Maintenance Fee Reminder Mailed
Critical
| 24 Jul, 2023 | US10493103 |
|
Expire Patent
Critical
| 21 Nov, 2022 | US10098910 |
| Post Issue Communication - Certificate of Correction | 18 Nov, 2022 | US9675639 |
|
Email Notification
Critical
| 19 Sep, 2022 | US9675639 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 19 Sep, 2022 | US9675639 |
|
Correspondence Address Change
Critical
| 13 Sep, 2022 | US9675639 |
|
Maintenance Fee Reminder Mailed
Critical
| 06 Jun, 2022 | US10098910 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 14 Apr, 2022 | US10493103 |
|
Email Notification
Critical
| 14 Apr, 2022 | US10493103 |
|
Email Notification
Critical
| 13 Apr, 2022 | US7381427 |
|
Correspondence Address Change
Critical
| 13 Apr, 2022 | US10493103 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 13 Apr, 2022 | US7381427 |
|
Correspondence Address Change
Critical
| 12 Apr, 2022 | US7381427 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 01 Dec, 2021 | US9980983 |
Aclaris's Family Patents
Aclaris Drug List
Given below is the complete list of Aclaris's drugs and the patents protecting them.
1. Eskata
Eskata is protected by 6 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9675639 | Peroxide formulations and methods and applicators for using the same |
04 Jul, 2035
(9 years from now)
| Active |
| US10098910 | Peroxide formulations and methods and applicators for using the same |
21 Apr, 2035
(9 years from now)
| Active |
| US10493103 | Peroxide formulations and methods and applicators for using the same |
21 Apr, 2035
(9 years from now)
| Active |
| US10729720 | Peroxide formulations and methods and applicators for using the same |
21 Apr, 2035
(9 years from now)
| Active |
| US9980983 | Peroxide formulations and methods and applicators for using the same |
21 Apr, 2035
(9 years from now)
| Active |
| US7381427 | Seborrheic keratosis treatment |
08 Jun, 2022
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Eskata's drug page